CervoMed【CRVO】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

2.4098

買値

2.20

売値

5.00

出来高

277,493

2.24 日の範囲 2.43

1.80 52 週間の範囲 26.3789

時価総額

19.89M

前日終値

2.23

始値

2.24

時刻

2.4

最終取引時間

財務取引量

US$ 652,844

VWAP

2.3527

平均取引量 (3 か月)

430,185

発行済株式数

8,253,741

配当利回り

PER

-16.72

1 株当たり利益 (EPS)

-0.26

歳入

7.15M

純利益

-2.17M

Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is tran... Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.cervomed.com

本社

Wilmington, Delaware, USA

設立

CervoMed Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker CRVO. The last closing price for CervoMed was US$2.23. Over the last year, CervoMed shares have traded in a share price range of US$ 1.80 to US$ 26.3789.

CervoMed currently has 8,253,741 shares in issue. The market capitalisation of CervoMed is US$18.41 million. CervoMed has a price to earnings ratio (PE ratio) of -16.72.

CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Dec. 12, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO) (the “Company”), a clinical stage company focused on developing treatments for age-related neurologic disorders, today...

Form 8-K - Current report

CervoMed Announces Topline Data from RewinD-LB Phase 2b Clinical Trial in Patients with Dementia with Lewy Bodies

—Neflamapimod did not demonstrate statistically significant effects versus placebo on primary and secondary endpoints at 16 weeks— —Favorable safety and tolerability results with no new safety...

Form 8-K - Current report

CervoMed Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia

Designation underscores significant unmet need in frontotemporal dementia and the potential role of neflamapimod in multiple neurologic disorders On track to report topline data from the RewinD-LB...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.0098	0.408333333333	2.4	2.51	2.17	267698	2.34615964	CS
4	-8.0402	-76.9397129187	10.45	14.4	1.8	1121329	2.53736675	CS
12	-10.0902	-80.7216	12.5	14.9999	1.8	430185	4.15064445	CS
26	-13.5802	-84.9293308318	15.99	20.63	1.8	240651	6.2334284	CS
52	-5.5802	-69.8397997497	7.99	26.3789	1.8	138329	7.68457965	CS
156	-11.0902	-82.1496296296	13.5	26.3789	1.8	111827	7.61101438	CS
260	-11.0902	-82.1496296296	13.5	26.3789	1.8	111827	7.61101438	CS

CRVO - Frequently Asked Questions (FAQ)

What is the current CervoMed share price?

The current share price of CervoMed is US$ 2.4098

How many CervoMed shares are in issue?

CervoMed has 8,253,741 shares in issue

What is the market cap of CervoMed?

The market capitalisation of CervoMed is USD 18.41M

What is the 1 year trading range for CervoMed share price?

CervoMed has traded in the range of US$ 1.80 to US$ 26.3789 during the past year

What is the PE ratio of CervoMed?

The price to earnings ratio of CervoMed is -16.72

What is the cash to sales ratio of CervoMed?

The cash to sales ratio of CervoMed is 5.08

What is the reporting currency for CervoMed?

CervoMed reports financial results in USD

What is the latest annual turnover for CervoMed?

The latest annual turnover of CervoMed is USD 7.15M

What is the latest annual profit for CervoMed?

The latest annual profit of CervoMed is USD -2.17M

What is the registered address of CervoMed?

The registered address for CervoMed is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the CervoMed website address?

The website address for CervoMed is www.cervomed.com

Which industry sector does CervoMed operate in?

CervoMed operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
FCUVFocus Universal Inc	US$ 0.9499 (174.93%)	260.93M
NITON2OFF Inc	US$ 2.6306 (145.85%)	358.28M
CRNCCerence Inc	US$ 19.33 (143.76%)	161.8M
KITTNauticus Robotics Inc	US$ 3.8249 (140.56%)	104.8M
ACONAclarion Inc	US$ 0.2984 (110.14%)	305.64M
HWHHWH International Inc	US$ 0.4621 (-28.80%)	7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF	US$ 5.69 (-26.30%)	24.77M
RAINRain Enhancement Technologies Holdco Inc	US$ 5.59 (-23.42%)	161.15k
PTLEPTL Ltd	US$ 9.35 (-23.30%)	1.04M
NXUNXU Inc	US$ 0.725868 (-22.78%)	7.59M
NITON2OFF Inc	US$ 2.6306 (145.85%)	358.28M
TGLTreasure Global Inc	US$ 0.382 (101.58%)	337.5M
ACONAclarion Inc	US$ 0.2984 (110.14%)	305.64M
FCUVFocus Universal Inc	US$ 0.9499 (174.93%)	260.93M
NVDANVIDIA Corporation	US$ 144.47 (4.45%)	230.01M